TY - JOUR
T1 - Limits of 18F-Fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor
AU - Giorgini, Margherita
AU - Marchetti, Claudia
AU - Di Donato, Violante
AU - Tesei, Jacopo
AU - Manci, Natalina
AU - Panici, Pierluigi Benedetti
PY - 2010
Y1 - 2010
N2 - Most borderline ovarian tumors (BOT) occur in young women and exhibit a low malignant behavior. Nevertheless, an accurate long-term follow-up is required because, frequently, recurrence arises after many years from primary treatment, especially in patients affected by BOTwith invasive peritoneal implants, which have aworse prognosis.We report the case of a pelvic recurrence of serous BOT firstly suspected by physical examination but misdiagnosed by 18F-fluorodeoxyglucose positron emission tomography and computed tomography and identified only by magnetic resonance imaging, 7 years after primary treatment. We also reviewed the literature concerning the role of 18F-fluorodeoxyglucose positron emission tomography in the management and follow-up of BOT. Copyright © 2010 by IGCS and ESGO.
AB - Most borderline ovarian tumors (BOT) occur in young women and exhibit a low malignant behavior. Nevertheless, an accurate long-term follow-up is required because, frequently, recurrence arises after many years from primary treatment, especially in patients affected by BOTwith invasive peritoneal implants, which have aworse prognosis.We report the case of a pelvic recurrence of serous BOT firstly suspected by physical examination but misdiagnosed by 18F-fluorodeoxyglucose positron emission tomography and computed tomography and identified only by magnetic resonance imaging, 7 years after primary treatment. We also reviewed the literature concerning the role of 18F-fluorodeoxyglucose positron emission tomography in the management and follow-up of BOT. Copyright © 2010 by IGCS and ESGO.
KW - Borderline ovarian tumors
KW - Recurrence
KW - Total-body FDG-PET/CT
KW - Borderline ovarian tumors
KW - Recurrence
KW - Total-body FDG-PET/CT
UR - http://hdl.handle.net/10807/205144
U2 - 10.1111/IGC.0b013e3181da2912
DO - 10.1111/IGC.0b013e3181da2912
M3 - Article
SN - 1048-891X
VL - 20
SP - 694
EP - 697
JO - International Journal of Gynecological Cancer
JF - International Journal of Gynecological Cancer
ER -